Solana (HSDT) vs Stereotaxis (STXS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Stereotaxis (STXS) has outperformed Solana (HSDT) over the past year, losing 68.9% versus a loss of 86.8%. Over five years, STXS leads with a -81.3% price change compared with -100.0% for HSDT. Solana is the larger company by market cap ($157.2 million vs $110.8 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSDT | STXS |
|---|---|---|
| Share price | $2.42 | $1.11 |
| Market cap | $157.23M | $110.75M |
| 1-day change | +1.47% | -0.42% |
| YTD return | -17.65% | -51.74% |
| 1-year return | -86.80% | -68.91% |
| 5-year return | -100.00% | -81.28% |
| P/E ratio (TTM) | 0.04 | — |
| EPS (TTM) | $53.74 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.81 | $3.42 |
| 52-week low | $1.19 | $1.09 |
| Distance from 52-week high | -85.63% | -67.68% |
| Analyst consensus | none | none |
| Avg. price target upside | +44.93% | +171.42% |
| Average volume | 351.13K | 808.41K |
| Shares outstanding | 65.10M | 100.20M |
| Employees | 21 | 131 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STXS has outperformed HSDT by 17.9 percentage points over the past year.
About Solana
HSDT stock →Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 21 employees
About Stereotaxis
STXS stock →Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 131 employees
HSDT vs STXS FAQ
Which is bigger, Solana or Stereotaxis?
Solana (HSDT) is larger, with a market capitalization of $157.23M compared with $110.75M for Stereotaxis (STXS).
Which stock has performed better over the past year, HSDT or STXS?
STXS returned -68.91% over the past 12 months, compared with -86.80% for HSDT (price return, excluding dividends). Past performance does not predict future results.
Are Solana and Stereotaxis in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.